Natera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Similar documents
ConvaTec Group Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bionure Farma SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile

DNA2.0 Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Glenmark Pharmaceuticals Inc., USA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Starpharma Holdings Limited (SPL) - Medical Equipment - Deals and Alliances Profile

Median Kliniken GmbH & Co. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

North China Pharmaceutical Group Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Pharmaxis Ltd (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile

Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Faes Farma SA (FAE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bioton SA (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile

DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Mindray Medical International Limited (MR) - Medical Equipment - Deals and Alliances Profile

Paramount Mining Corporation Limited (PCP) - Metals and Mining - Deals and Alliances Profile

Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

The Walt Disney Company - Strategy, SWOT and Corporate Finance Report

Gap, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Kohler Co. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

McCain Foods Limited, Inc. - Strategic SWOT Analysis Review

Phone: +44 (0) or BioPortfolio Limited

Vorwerk and Co. KG - Strategy, SWOT and Corporate Finance Report

Maruti Suzuki India Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Compression Therapy - Medical Devices Pipeline Assessment, 2017

Surgical Sutures Market By Product Type [Automated Suturing Devices (Disposable Automated Suturing Devices, And Re-Usable Automated Suturing

Critical Limb Ischemia - Pipeline Review, H1 2017

Johnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile

PwC Deals $42B. Global Pharma & Life Sciences Deals Insights Q Update

Digital Health Funding and M&A

Generics Series: Authorized Generics Analysis Stemming the Generics Tide

April By Type of Approach- Transfemoral and Transapical. By Region- North America, Europe, APAC and RoW

VentureSource Europe -- 3Q 2014

United States Sterilization Equipment Market Outlook to 2021

1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Global Neurostimulation Devices Market - An Overview 3.

Global Paper Stationery Market Research Report 2016

WOLPERT ASSOCIATES, INC. Strategic Advisory Services Firm Overview

Global Absolute Pressure Transmitters Market Research Report 2016

Global DAW Software Market Research Report 2016

Fall State of the Industry Report UF SID MARTIN FLORIDA BIODATABASE

HBM Healthcare Investments Ltd Access to a Global and Diversified Private Equity Healthcare Portfolio

Venture Capital Report

Dealdoc. Acquisition agreement for Gambro. Baxter International Gambro. Dec , Wildwood Ventures Ltd. All rights reserved.

Venture Capital Report

Mara H. Rogers, Partner Norton Rose Fulbright

Indoor Positioning and Navigation System Market Research Report- Forecast 2023

Pharma - Biotech Collaborations: Optimizing Success, Minimizing Risk and Maintaining Alignment

China Ophthalmic Hospital Industry Report, May 2013

Roche's Global IP Strategy 10th. JIPA IP Symposium, Tokyo Dr. Axel Braun F. Hoffmann La Roche Ltd.

Military Robotics - Emerging Trends and Future Outlook. Reference code: DF4580PR Published: July 2015 Single user price: US$1950

Venture Capital Report

VentureSource U.S. -- 4Q 2013

World Offshore Wind Market Forecast Prospects, Technologies, World Markets

2013 Global venture capital confidence survey results. How confident are investors?

Global Sequins Apparels Market Research Report 2016

Intellectual property governance and strategic value creation:

GLOBAL RISK AND INVESTIGATIONS JAPAN CAPABILITY STATEMENT

Venture Capital Report

Purvi B. Maniar Member of the Firm

Global Source Ventures, LLC Introduction. Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner

How attractive is the BioRegion of Catalonia for foreign investment? Guy Nohra Co-Founder and Managing Director of Alta Partners

Financing Sources, Sales Pitch to Investors BARCELONA Aitana Peire Venture Valuation

PitchBook. Bet ter Data. Bet ter Decisions. 4Q 2012 Private Equity. Company Inventory. Report. Sponsored by:

Robert A. Greising Partner

New York Bar admission (or eligibility to obtain admission promptly) is required.

Commercialization Strategies that Work

2014 Global venture capital confidence survey results

Global and China Industrial Robot Industry Report, Sep. 2013

Nasir, Dao PKM Abdul Partner PwC Legal (Vietnam) Co., Ltd

EXECUTIVE SUMMARY. Investment Opportunity. Paradox Financial Solutions Inc.

Robert A. Greising Partner

FUNDS DATABASE SCOPE INCLUSION CRITERIA DATA HIGHLIGHTS

Implantable Drug Delivery Devices Market - Global Industry Analysis, Size, Share, Trends And Forecast,

IVC-MEITAR HIGH-TECH EXITS H1/ 2015 REPORT. IVC-Meitar 2014 Exits Report Prepared by IVC Research Center Ltd.

Advisors. Firm Overview

Cherry AB. Investing in a broad gaming portfolio. CEO Anders Holmgren GP Bullhound 6 December 2017

executives are often viewed to better understand the merits of scientific over commercial solutions.

Global and China Industrial Robot Speed Reducer Industry Report, Jun. 2014

Licensing League Tables 3Q14

Q&A with Samira Salman

Venture Capital Report

CANADIAN PRIVATE EQUITY BUYOUT REVIEW

François G. Laugier's Representative Experience

Singular ID. The Story of Commercialising a Materials Technology in Singapore. Adrian Burden

Chartwell Introduction and AEC Capabilities

Venture Capital Report

Transaction Services. Member of Invest Europe and SECA Swiss Priva te E quity & Corporate Finance Association

AFTER NEARLY 3 YEARS OF STEADY GROWTH, U.S. VENTURE INVESTMENT PULLS BACK 7% IN 1 ST QUARTER TO $6.84 BILLION

Private Equity & Management Buy-Outs This course is presented in London on: 25 January 2018, 18 May 2018, 25 October 2018

gellerbiopharm A healthcare investment banking division of Financial West Group, member FINRA/SIPC. Office (212) Web gellerbp.

Perspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond

VentureSource China -- 1Q 2014

China Industrial Robot Industry Report, Feb. 2012

Transcription:

Natera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Natera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen years. BioPortfolio offers a personal service to our customers with dedicated research managers who will work with you to source the best report for your needs. Based in the UK, BioPortfolio is well positioned to coordinate our customers' orders sourced from over 50 global report publishers. We are pleased to present details of this report to assist your buying decision and administrative process. You will find easy-to-use How To Buy information on the last page of this document. We look forward to being of service to you. If you have bulk and/or recurring requirements, please get in touch - we can liaise with publishers to obtain sample pages and negotiate discounts on your behalf. Phone: +44 (0)1300 321501 or Email: reportstore@bioportfolio.com 2

Natera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Natera, Inc (Natera), formerly Gene Security Network, Inc is a biotechnology company that develops bioinformatics technologies to check small quantities of genetic material. The company s products include panorama prenatal testing, miscarriage testing, pre-implantation genetic testing, genetic carrier screening and paternity testing. Its pre-implantation genetic testing includes aneuploidy screening, translocation testing and single gene testing. Natera is used for the treatment of cystic fibrosis, fragile X syndrome, spinal muscular atrophy, bloom syndrome, canavan disease, Niemann-pick disease Type A and familial dysautonomia among others. Natera is headquartered in San Carlos, California, the US. Natera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma etrack deals database, and primary and secondary research. Scope - Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company's operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. 3

- Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Additional Details Publisher : Global Data Reference : GDPH178267D Number of Pages : 22 Report Format : PDF Publisher Information : 4

5

Table Of Contents for Natera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Table of Contents Table of Contents 2List of Tables 3List of Figures 4Natera, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 4Natera, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6Natera, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7Natera, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8Natera, Inc., Medical Devices Deals, 2010 to YTD 2016 9Natera, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10Natera, Inc., Pharmaceuticals & Healthcare, Deal Details 11Venture Financing 11Natera Raises USD55.5 Million in Venture Financing 11Natera Raises US$54.6 Million In Venture Financing 13Licensing Agreements 15MedGenome Enters into Licensing Agreement with Natera for NIPT 15Equity Offering 16Natera Prices IPO for USD180 Million 16Natera, Inc. - Key Competitors 18Key Employees 19Locations And Subsidiaries 21Head Office 21Appendix 22Methodology 22About GlobalData 22Contact Us 22Disclaimer 22 6

List Of Tables in Natera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile List of Tables Natera, Inc., Pharmaceuticals & Healthcare, Key Facts, 2014 1 Natera, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5 Natera, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6 Natera, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7 Natera, Inc., Deals By Therapy Area, 2010 to YTD 2016 8 Natera, Inc., Medical Devices Deals, 2010 to YTD 2016 9 Natera, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10 Natera Raises USD55.5 Million in Venture Financing 11 Natera Raises US$54.6 Million In Venture Financing 13 MedGenome Enters into Licensing Agreement with Natera for NIPT 15 Natera Prices IPO for USD180 Million 16 Natera, Inc., Key Competitors 18 Natera, Inc., Key Employees 19 7

List Of Figures, Charts and Diagrams in Natera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile List of Figures Natera, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1 Natera, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1 Natera, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1 Natera, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1 Natera, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5 Natera, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6 Natera, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7 Natera, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8 Natera, Inc., Medical Devices Deals, 2010 to YTD 2016 9 8

How to Buy... Natera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Option 1 - Online Go to our website and pay online with any major debit or credit card: Option 2 - Request a Proforma Invoice Fill in the details below, and either Scan this page and email it to us at reportstore@bioportfolio.com or Fax it to us at +44 (0)1305 791844.We will send you a Proforma Invoice and deliver your report on settlement. Your Name: Job Title: Your Email: Your Contact Phone: Company Name: Address: Post/Zip Code: Country: P.O. Number: Any Other Instructions: Pricing Options: (please tick one) $250 Single User Price $500 Site License Price $750 Enterprise License Price Payment Options: (please tick one) Online Credit Card (we will email you the invoice with a payment link) Direct Wire Transfer (we will email you the invoice with our bank details) Authorising Signature: Option 3 - Phone Us on +44 (0)1300 321501 We will be delighted to give you our personal attention. 9